SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-313228
Filing Date
2013-08-01
Accepted
2013-07-31 19:31:54
Documents
10
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d530825d10q.htm 10-Q 620902
2 EX-31.1 d530825dex311.htm EX-31.1 6344
3 EX-31.2 d530825dex312.htm EX-31.2 6350
4 EX-32.1 d530825dex321.htm EX-32.1 3796
  Complete submission text file 0001193125-13-313228.txt   5022851

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT epzm-20130630.xml EX-101.INS 452732
6 XBRL TAXONOMY EXTENSION SCHEMA epzm-20130630.xsd EX-101.SCH 29777
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE epzm-20130630_cal.xml EX-101.CAL 42749
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE epzm-20130630_def.xml EX-101.DEF 57701
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE epzm-20130630_lab.xml EX-101.LAB 259885
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE epzm-20130630_pre.xml EX-101.PRE 170555
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35945 | Film No.: 131000491
SIC: 2834 Pharmaceutical Preparations